A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy

Conditions: Essential Hypertension; Type 2 Diabetes Mellitus Interventions: Drug: BR1019A; Drug: BR1019B; Drug: BR1019C; Drug: BR1019A-1; Drug: BR1019B-1; Drug: BR1019C-1 Sponsors: Boryung Pharmaceutical Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials